Skip to main content

Mirion Technologies, Inc. (MIR) Stock Analysis

Recovery setup

HoldVALUE-TRAP 1/5Moderate Confidence

Industrials · Specialty Industrial Machinery

Hold if already holding. Not a fresh buy at $19.20, but acceptable to hold if already in. Reasons: Concentration risk — Supplier: sole or limited source suppliers; Negative momentum.

Mirion Technologies provides radiation safety products, services, and software across Nuclear & Safety (nuclear plants, labs, defense) and Medical (cancer treatment delivery and diagnostics) segments. It sells instruments and systems globally to nuclear facilities, hospitals,... Read more

$19.20+27.9% A.UpsideScore 5.6/10#11 of 48 Specialty Industrial Machinery
Stop $17.78Target $24.45(analyst − 13%)A.R:R 2.3:1
Analyst target$28.10+46.4%10 analysts
$24.45our TP
$19.20price
$28.10mean
$29

Hold if already holding. Not a fresh buy at $19.20, but acceptable to hold if already in. Reasons: Concentration risk — Supplier: sole or limited source suppliers; Negative momentum. Chart setup: Death cross but MACD improving, RSI 48. Mixed signals. Hold existing position. Score 5.6/10, moderate confidence.

Passes 5/7 gates (favorable risk/reward ratio, clean insider activity, no SEC red flags, earnings proximity 89d clear, semi cycle peak clear). Fails on weak momentum and death cross (50MA < 200MA). Suitability: aggressive.

Thesis

Rewards
Strong earnings beat streak (3/4)
Strong growth profile
Analyst upside: 28%
Risks
Concentration risk — Supplier: sole or limited source suppliers
Negative momentum
Below 200-day MA

Key Metrics

P/E (TTM)186.6
P/E (Fwd)28.0
Mkt Cap$4.7B
EV/EBITDA26.3
Profit Mgn2.6%
ROE1.5%
Rev Growth27.5%
Beta1.09
DividendNone
Rating analysts15

Quality Signals

Piotroski F9/9

Options Flow

P/C0.89neutral
IV55%elevated
Max Pain$13-34.9% vs spot

Concentration Risks(10-K Item 1A)

  • MEDIUMGeographicinternational (outside North America)37%
    10-K Item 1A: 'Revenue generated from outside of North America accounted for approximately 37.1% of our net sales for the year ended December 31, 2025'
  • HIGHSuppliersole or limited source suppliers
    10-K Item 1A: 'We rely on third party suppliers for our manufacturing operations including from sole or limited source suppliers'

Material Events(8-K, last 90d)

  • 2026-04-13Item 5.02LOW
    CEO/Chairman Thomas Logan received special one-time grant of 2,500,000 performance vesting stock options on April 9, 2026, tied to TSR vs. Russell 2000 over three- and four-year periods. No departure; compensatory arrangement only.
    SEC filing →

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer

Rating Breakdown

2 floor-breakers·1 ceiling hit

Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static

Volume
0.0
Obv
1.0
Ma Position
1.5
Rsi
4.5
Macd
6.1
Volume distribution (falling OBV)Below 200-MA, MA slope flat

Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static

Quality Rank
1.3
Value Rank
1.4
Growth Rank
9.1
Industry growth leader
GatesMomentum 2.6<4.5Death cross (50MA < 200MA)A.R:R 2.3 ≥ 1.5Insider activity: OKNo SEC red flagsEARNINGS PROXIMITY 89d clearSEMI CYCLE PEAK CLEARRecoverySuitability: Aggressive
RSI
48 · Neutral
20D MA 50D MA 200D MADEATH CROSSSupport $16.84Resistance $20.60

Price Targets

$18
$24
A.Upside+27.3%
A.R:R2.3:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeSteady

Risk Alerts

! Momentum score 2.6/10 — below 4.5 minimum
! Death cross — 50-day MA below 200-day MA

Earnings

B
B
B
M
3/4 beats
Next Earnings2026-07-28 (89d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is MIR stock a buy right now?

Hold if already holding. Not a fresh buy at $19.20, but acceptable to hold if already in. Reasons: Concentration risk — Supplier: sole or limited source suppliers; Negative momentum. Chart setup: Death cross but MACD improving, RSI 48. Mixed signals. Hold existing position. Target $24.45 (+27.3%), stop $17.78 (−8.0%), A.R:R 2.3:1. Score 5.6/10, moderate confidence.

What is the MIR stock price target?

Take-profit target: $24.45 (+27.9% upside). Target $24.45 (+27.3%), stop $17.78 (−8.0%), A.R:R 2.3:1. Stop-loss: $17.78.

What are the risks of investing in MIR?

Concentration risk — Supplier: sole or limited source suppliers; Negative momentum; Below 200-day MA.

Is MIR overvalued or undervalued?

Mirion Technologies, Inc. trades at a P/E of 186.6 (forward 28.0). TrendMatrix value score: 5.6/10. Verdict: Hold.

What do analysts say about MIR?

15 analysts cover MIR with a consensus score of 4.1/5. Average price target: $28.

What does Mirion Technologies, Inc. do?Mirion Technologies provides radiation safety products, services, and software across Nuclear & Safety (nuclear plants,...

Mirion Technologies provides radiation safety products, services, and software across Nuclear & Safety (nuclear plants, labs, defense) and Medical (cancer treatment delivery and diagnostics) segments. It sells instruments and systems globally to nuclear facilities, hospitals, and government agencies, with presence in over 98% of nuclear power plants and 80% of cancer centers worldwide.

Related stocks: EPAC (Enerpac Tool Group Corp.) · CXT (Crane NXT, Co.) · AMSC (American Superconductor Corpora) · JBTM (JBT Marel Corporation) · GTES (Gates Industrial Corporation pl)